WHO ICTRP trial
A study to assess the effect of desidustat in comparison to erythropoietin in…
CTRI/2024/02/062658 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/02/062658 |
|---|---|
| Public title | A study to assess the effect of desidustat in comparison to erythropoietin in patients of anemia with chronic kidney disease. |
| Scientific title | Randomized controlled trial to compare the safety and efficacy of desidustat with erythropoietin in adult patient suffering from anemia in chronic kidney disease. - nil |
| Primary sponsor | Dr Sachin Sharma |
| Secondary sponsors | MultiDisciplinary Research Unit |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: N189- Chronic kidney disease, unspecified |
| Interventions | Intervention1: Desidustat: Tab desidustat 50 mg orally three times a week with maximum dose increased Upto 150 mg three times a week depend on hemoglobin level. Control Intervention1: Erythropoietin: Erythropoietin injection subcutaneous 50… |
| Registration date | Feb 14, 2024 |
| Target size | 90 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: